These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Danazol - effective second line therapy in idiopathic thrombocytopenic purpura in children. Three case reports].
    Author: Szmydki-Baran A, Adamowicz-Salach A, Gołebiowska-Staroszczyk S.
    Journal: Med Wieku Rozwoj; 2008; 12(4 Pt 2):1130-4. PubMed ID: 19531838.
    Abstract:
    Danazol is an accredited second line drug for idiopathic thrombocytopenic purpura (ITP) in adults. There are very few positions in the literature about using danazol in children, although some articles quote its evident efficacy. In this paper we present three cases of children treated with danazol. The routine treatment in these ITP cases was ineffective. The result was stabilization of platelet count and avoidance of splenectomy.
    [Abstract] [Full Text] [Related] [New Search]